Drugs -- Law and legislation -- United States
Resource Information
The concept Drugs -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library - University of Pennsylvania Law School.
The Resource
Drugs -- Law and legislation -- United States
Resource Information
The concept Drugs -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library - University of Pennsylvania Law School.
- Label
- Drugs -- Law and legislation -- United States
253 Items that share the Concept Drugs -- Law and legislation -- United States
Context
Context of Drugs -- Law and legislation -- United StatesSubject of
No resources found
No enriched resources found
- "Medical" marijuana, federal drug law, and the constitution's supremacy clause : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001
- "Medical" marijuana, federal drug law, and the constitution's supremacy clause : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001
- A Legislative history of the Federal food, drug, and cosmetic act and its amendments
- A nation of guinea pigs
- A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003
- A treatise on the law of food, drugs, and cosmetics
- A treatise on the law of foods, drugs and cosmetics
- ANDA litigation : strategies and tactics for pharmaceutical patent litigators
- ANDA litigation : strategies and tactics for pharmaceutical patent litigators
- American pure food and drug laws : comprising the statutes of the United States and of the several states of the Union on the subject of foods and drugs, their manufacture, sale and distribution, whether in interstate or foreign commerce; the administrative rules and regulations of the federal and state departments and commissioners, and the standards of purity, etc. : to which are added chapters on related subjects, such as insecticides and fungicides, commercial feeding stuffs, etc., with full editorial commentaries and numerous citations to federal and state decisions
- An Act to Amend Title 38, United States Code, to Clarify the Authority of the Secretary of Veterans Affairs to Disclose Certain Patient Information to State Controlled Substance Monitoring Programs, and for Other Purposes
- An Act to Amend the Controlled Substances Act with Regard to the Provision of Emergency Medical Services
- An Act to Amend the Federal Food, Drug, and Cosmetic Act to Authorize Additional Emergency Uses for Medical Products to Reduce Deaths and Severity of Injuries Caused by Agents of War, and for Other Purposes
- An Act to Extend the Temporary Scheduling Order for Fentanyl-Related Substances, and for Other Purposes
- An Act to Prevent the Illegal Manufacturing and Use of Methamphetamine
- An act to protect the public health by amending the Federal Food, Drug, and Comestic Act to consolidate certain provisions assuring the safety and effectiveness of new animal drugs, and for other purposes
- Animal Drug Amendments of 1965 : hearing before the Subcommittee on Public Health and Welfare of the Committee on Interstate and Foreign Commerce, House of Representatives, Eighty-ninth Congress, second session on H.R. 7655, H.R. 7797, H.R. 7815, H.R. 8377, H.R. 9542, bills to protect the public health by amending the Federal Food, Drug and Cosmetic Act to consolidate certain provision assuring the safety and effectiveness of new animal drugs, and for other purposes, June 13, 1966
- Animal Drug Availability Act of 1996 : P.L. 104-250, 110 Stat. 3151, October 9, 1996
- Animal Medicinal Drug Use Clarification Act of 1994 : P.L. 103-396, 108 Stat. 4153, October 22, 1994
- Animal drug amendments of 1965. : Hearing, Eighty-ninth Congress, second session. June 13, 1966
- Animal drug amendments of 1967. : Hearing, Ninetieth Congress, first session, on H.R. 3639. October 3, 1967
- Animal drug amendments of 1968 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninetieth Congress, second session on S. 1600 and H.R. 3639, to protect the public health by amending the Federal food, drug, and cosmetic act to consolidate certain provisions assuring the safety and effectiveness of new animal drugs, and for other purposes, May 24, 1968
- Animal drug amendments of 1968. : Hearing, Ninetieth Congress, second session ... May 24, 1968
- Annual reports 1950-1974 on the administration of the Federal food, drug, and cosmetic act and related laws
- Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992
- Arzneimittelhaftung in den USA und Deutschland
- Basic outlines on drug law and regulation
- Basic outlines on food and drug law and regulation
- Biodefense and Pandemic Vaccine and Drug Development Act of 2006 : report (to accompany H.R. 5533) (including cost estimate of the Congressional Budget Office)
- Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12 2003
- Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12, 2003
- Child safety act and personnel training. : Hearings, Eighty-ninth Congress, second session
- Comparison of bills to regulate controlled dangerous substances and to amend the narcotic and drug laws
- Comparison of bills to regulate controlled dangerous substances and to amend the narcotic and drug laws
- Compilation of food and drug laws
- Compilation of laws enforced by the U.S. Food and Drug Administration and related statutes
- Compilation of selected acts within the jurisdiction of the Committee on Energy and Commerce : food, drug, and related law : including Federal Food, Drug, and Cosmetic Act, Controlled Substances Act ...
- Compilation of selected acts within the jurisdiction of the Committee on Energy and Commerce : including Federal Food, Drug, and Cosmetic Act, Controlled Substances Act ..., Food, drug, and related law
- Compilation of selected public health laws, Volume II, Food, drug, and related law, including Federal Food, Drug, And Cosmetic Act, Controlled Substances Acts, Narcotic Addict Rehabilitation Act of 1966, Federal hazardous Substances Act, Fair Packaging and Labeling Act, Poison Prevention Packaging Act, Flammable Fabrics Act, Federal Cigarette Labeling and Advertising Act, Consumer Product Safety Act, Tea Importation Act, Federal Import Milk Act, Filled Milk, Federal Caustic Poison Act
- Comprehensive Methamphetamine Control Act of 1996 : P.L. 104-237, 110 Stat. 3009, October 3, 1996
- Comprehensive Methamphetamine Control Act of 1996 : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3852 ... September 5, 1996
- Constitutional questions in food and drug laws
- Constitutional questions in food and drug laws
- Control of psychotoxic drugs : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Eighty-eighth Congress, second session, on S. 2628, a bill to protect the public health by amending the Federal food, drug, and cosmetic act to regulate the manufacture, compounding, processing, distribution, delivery, and possession of phychotoxic drugs, August 3, 1964
- Controlled Substances Export Reform Act of 2005 : report (to accompany H.R. 184) (including cost estimate of the Congressional Budget Office)
- Controlled Substances Trafficking Prohibition Act and Correction Officers Health and Safety Act of 1997 : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, on H.R. 3633 and H.R. 2070, March 26, 1998
- Controlled Substances Trafficking Prohibition Act and Correction Officers Health and Safety Act of 1997 : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, on H.R. 3633 and H.R. 2070, March 26, 1998
- Controlled dangerous substances, narcotics, and drug control laws. : Hearings, Ninety-first Congress, second session
- Controlled substances act extension : hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-third Congress, second session, on H.R. 14213 ... June 6, 1974
- Coordinated Response through Interagency Strategy and Information Sharing Act : report (to accompany H.R. 5925) (including cost estimate of the Congressional Budget Office)
- Counterfeit Drug Penalty Enhancement Act of 2012 : report (to accompany H.R. 3668) (including cost estimate of the Congressional Budget Office)
- Counterfeit bulk drugs : hearings before ... 106th Congress, 2nd session, June 8 and October 3, 2000
- Decisions of courts in cases under the Federal Food and Drugs Act
- Digest of laws and regulations in force in the United States relating to the possession, use, sale, and manufacture of poisons and habit-forming drugs
- Digest of laws and regulations in force in the United States relating to the possession, use, sale, and manufacture of poisons and habit-forming drugs
- Discussion draft of the Food and Drug Administration Globalization Act legislation : drug safety : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 1, 2008
- Drug & cosmetics law reporter (CCH)
- Drug Abuse Prevention Act oversight. : Hearings, Ninety-second Congress, second session
- Drug Industry Act of 1962 : report [to accompany S. 1552]
- Drug Price Competition & Patent Term Restoration Act of 1984 : P.L. 98-417, 98 Stat. 1585, September 24, 1984
- Drug abuse & the law sourcebook
- Drug abuse and the law sourcebook
- Drug abuse and the law sourcebook
- Drug abuse control amendments of 1965. : Hearings, Eighty-ninth Congress, first session, on H.R. 2
- Drug abuse control amendments--1970. : Hearings, Ninety-first Congress, second session, on H.R. 11701 and H.R. 13743
- Drug abuse office and treatment act amendments of 1975 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, first session, on H.R. 7547 ... and H.R. 4819 ... June 10 and 11, 1975
- Drug abuse prevention act oversight. : Hearings, Ninety-second Congress, second session
- Drug abuse prevention and control
- Drug abuse prevention and treatment legislation, 1975 : hearings before the Subcommittee on Alcoholism and Narcotics of the Committee on Labor and Public Welfare, United States Senate, Ninety-fourth Congress, first session ... March 24 and 25, 1975
- Drug abuse prevention, treatment, and rehabilitation act of 1979 : hearing before the Subcommittee on Alcoholism and Drug Abuse of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on S. 525 ... March 2, 1979
- Drug abuse, prevention, treatment, and rehabilitation, 1971. : Hearings, Ninety-second Congress, first session, on S. 2217 ... August 2, 4, and 5, 1971
- Drug abuse, the pharmacist : hearing before the Subcommittee to Investigate Juvenile Delinquency of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session, pursuant to S. Res. 255, Section 12 ... March 28, 1974
- Drug amendments of 1962 : report to accompany H.R. 11581
- Drug control : high intensity drug trafficking areas' efforts to link investigations to international drug traffickers : report to the Senate and House Committees on Appropriations
- Drug efficacy. : Hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, first session
- Drug industry act of 1962. : Hearings before the Committee on Interstate and Foreign Commerce, House of Representatives, Eighty-seventh Congress, second session on H.R. 11581, ... and H.R. 11582 ... June 19, 20, 21, 22, August 20, 21, 22, 23, 1962
- Drug industry antitrust act : Hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty-seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs and for other purposes
- Drug listing act, 1971. : Hearing, Ninety-second Congress, first session, on S. 2167 ...
- Drug product liability
- Drug product liability - index
- Drug products : labeling, packaging, regulation
- Drug registration and listing instruction booklet
- Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 11611 (and all other similar and identical bills)
- Drug regulation reform act of 1979 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on S. 1075 ... May 17 and 18, 1979
- Drug safety amendments of 1976 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session
- Drug wars : how big pharma raises prices and keeps generics off the market
- Drug wars : how big pharma raises prices and keeps generics off the market
- Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992
- Drugs and justice : seeking a consistent, coherent, comprehensive view
- Drugs and the public
- Drugs, dignity, and death : physician-assisted suicide? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Fifth Congress, on S. 2151 ... July 31, 1998
- Drugs, dignity, and death : physician-assisted suicide? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Fifth Congress, second session, on S. 2151 ... July 31, 1998
- Enforcement of federal drug laws : strategies and policies of the FBI and DEA : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fourth Congress, first session, March 30, 1995
- Ensuring Patient Access and Effective Drug Enforcement Act of 2014 : report (to accompany H.R. 4709) (including cost estimate of the Congressional Budget Office)
- Ensuring Patient Access and Effective Drug Enforcement Act of 2015 : report (to accompany H.R. 471) (including cost estimate of the Congressional Budget Office)
- Ensuring Patient Access and Effective Drug Enforcement Act of 2016
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- Examination of the pharmaceutical industry, 1973-74 : hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, first and second sessions, on S. 3441 and S. 966
- Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Examining legislative proposals to combat our nation's drug abuse crisis : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, October 8 & 20, 2015
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002
- FDA advertising & promotion manual
- FDA enforcement manual
- FDA export reform
- FDA in the twenty-first century : the challenges of regulating drugs and new technologies
- FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives
- FDA's creative application of the law : not merely a collection of words : a consideration of FDA's implementation of its statutory authority to adapt to the practical demands on regulation presented by innovation, increased scientific understanding, limited resources, and change in public health policy
- Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712)
- Federal Food, Drug, and Cosmetic Act : a statement of its legislative record
- Federal Food, Drug, and Cosmetic Act : judicial and administrative record, 1938-1949
- Federal Food, Drug, and Cosmetic Act : judicial and administrative record, 1949-1950
- Federal Food, Drug, and Cosmetic Act : judicial and administrative record, 1951-1952
- Federal Food, Drug, and Cosmetic Act : judicial and administrative record, 1953-1957
- Federal Food, Drug, and Cosmetic Act : judicial and administrative record, 1953-1957
- Federal Food, Drug, and Cosmetic Act with amendments
- Federal Food, Drug, and Cosmetic Act with amendments
- Federal Food, Drug, and Cosmetic Act, as Amended, and related laws
- Federal Food, Drug, and Cosmetic Act, as amended
- Federal Food, Drug, and Cosmetic Act, as amended February 1998
- Federal drug abuse and drug dependence prevention, treatment, and rehabilitation act of 1970. : Hearings before the Special Subcommittee on Alcoholism and Narcotics of the Committee on Labor and Public Welfare, United States Senate, Ninety-first Congress, second session, S. 3562
- Federal drug abuse and drug dependence prevention, treatment, and rehabilitation act of 1971 ; : bill text and section-by-section analysis of S. 1835
- Federal drug abuse and drug dependence prevention, treatment, and rehabilitation act of 1971 ; : bill text and section-by-section analysis of S. 2217
- Federal drug offenses : departures from sentencing guidelines and mandatory minimum sentences, fiscal years 1999-2001
- Federal food, drug and cosmetic act. : Hearings before the Committee on Interstate and Foreign Commerce, House of Representatives, Eighty-second Congress, first session, on H.R. 3298, a bill to amend section 503(b) of the Federal food, drug and cosmetic act
- Federal food, drug and cosmetic law : administrative reports, 1907-1949
- Federal food, drug, and cosmetic act : judicial and administrative record, 1949-50
- Federal food, drug, and cosmetic act : judicial and administrative record, 1951-1952
- Federal food, drug, and cosmetic act ; : judicial and administrative record, 1938-1949
- Federal food, drug, and cosmetic act ; : judicial and administrative record, 1958-1960
- Federal food, drug, and cosmetic act ; : judicial and administrative record, 1961-1964
- Federal regulation of the drug industry
- Food & Drug Administration guides & manuals
- Food & Drug Administration, fourth edition
- Food and Drug Administration
- Food and Drug Administration Reform Act of 2012 : report (to accompany H.R. 5651) (including cost estimate of the Congressional Budget Office)
- Food and Drugs Act, June 30, 1906, and amendments of August 23, 1912 and March 3, 1913 : with the rules and regulations for the enforcement of the act, food inspection decisions, selected court decisions, digest of decisions, opinions of the Attorney General, and appendix
- Food and drug administration
- Food and drug administration
- Food and drug compliance : minimizing product liability exposure
- Food and drug law : federal regulation of drugs, biologics, medical devices, foods, dietary supplements, personal care, veterinary and tobacco products
- Food and drug legislation in the New Deal
- Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2135 ... May 19, 1992
- Food, Drug, Cosmetic, and Device Safety Amendments of 1992 : report together with dissenting views (to accompany H.R. 3642) (including cost estimate of the Congressional Budget Office)
- Food, drug & cosmetics law reporter (CCH)
- Food, drug & devices (CCH)
- Food, drug, and cosmetic act amendments of 1977 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session, on S. 1831 ... July 26 and 27, 1977
- Food, drug, and cosmetic industry
- Food, drug, cosmetic law reporter
- Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991
- Foods, drugs, and cosmetics. : Hearings before the Committee on commerce, United States Senate, Seventy-third Congress, second session, on S. 2800, a bill to prevent the manufacture, shipment, and sale of adulterated or misbranded food, drink, drugs, and cosmetics, and to regulate traffic therein; to prevent the false advertisement of food, drink, drugs, and cosmetics; and for other purposes. February 27 to March 3, 1934
- Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991
- H.R. 1963, the substitute prescription drug act : report of the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session
- Handbook of Federal narcotic and dangerous drug laws
- Handbook of federal drug law
- Handbook of federal narcotic and dangerous drug laws
- Imported Pharmaceutical Safety : Miami International Mail-Branch Facility Visit in Mar. 2003 : Memorandum
- Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014
- Increased controls over hallucinogens and other dangerous drugs. : Hearings, Ninetieth Congress, second session, on H.R. 14096 ... [and] H.R. 15355
- Intellectual property and health technologies : balancing innovation and the public's health
- Interagency coordination in drug research and regulation
- Interim reports
- Legislative and administrative changes needed to improve regulation of drug industry : report to the Congress
- Legislative history of Drug listing act (H.R. 4749, H.R. 9936, as reported, and H. Rept. 92-437)
- Lethal Drug Abuse Prevention Act of 1998 : hearing before the Subcommittee on the Constitution of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, on H.R. 4006, July 14, 1998
- Life sciences compliance : a pre-market and post-market road map
- Life sciences law : federal regulation of drugs, biologics, medical devices, foods, and dietary supplements
- Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce
- Mailing of drug samples to government officials for analysis. : Hearings before the Investigations Subcommittee and the Subcommittee on Postal Facilities and Mail of the Committee on Post Office and Civil Service, Ninety-second Congress, second session on H.R. 12383
- Materials prepared by the Administration relating to proposed legislation to regulate controlled dangerous substances and amend narcotics and drug laws : including the President's message, proposed bills, and other material prepared by the Dept. of Justice
- Methamphetamine Epidemic Elimination Act : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Ninth Congress, first session, on H.R. 3889, September 27, 2005
- Methamphetamine and Club Drug Anti-Proliferation Act of 2000 : report (to accompany H.R. 2987)
- Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017
- More information for better patient care : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477, to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products, February 22, 1996
- New approaches to drug policies : a time for change
- New drugs
- Notification of initiation or discontinuance of drug manufacture. : Hearing, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963 ... June 10, 1971
- Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office)
- Orphan Drug Amendments of 1985 : P.L. 99-91, 99 Stat. 387, August 15, 1985
- Orphan Drug Amendments of 1988 P.L. 100-290, 102 Stat. 90, April 18, 1988
- Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994
- Oversight--drug abuse prevention legislation. : Hearing, Ninety-third Congress, first session ...
- Pain Relief Promotion Act : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, second session on H.R. 2260, April 25, 2000
- Pain Relief Promotion Act of 1999 : hearing before the Subcommittee on the Constitution of the Committee on the Judiciary, House of Representatives, One Hundred Sixth Congress, first session, on H.R. 2260, June 24, 1999
- Pain Relief Promotion Act of 1999 : report together with dissenting views (to accompany H.R. 2260) (including cost estimate of the Congressional Budget Office)
- Pain management and improving end-of-life care : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session, on ... S. 1272 ... and S. 941 ... October 13, 1999
- Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
- Pediatric Research Equity Act of 2003 : report together with additional views (to accompany S. 650)
- Pharma & life sciences
- Pharmaceutical and medical device law : regulation of research, development, and marketing
- Pharmaceutical and medical device law : regulation of research, development, and marketing
- Pharmaceutical law : regulation of research, development, and marketing
- Pharmaceutical law : regulation of research, development, and marketing
- Pharmaceutical litigation
- Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies and S. 1277, a bill to provide equitable relief for the generic drug and for other purposes, February 27, and March 5, 1996
- Pharmacopolitics : drug regulation in the United States and Germany
- Pharmacy and the law
- Pharmacy practice for trial lawyers
- Prepared statements presented by Administration witnesses : appearing before the Committee on Ways and Means at hearings on legislation to regulate controlled dangerous substances and to amend narcotics and drug laws, together with the Administration's proposal, H.R. 17463, and other material prepared by the Department of Justice
- Prescription Drug Amendments of 1992 : P.L. 102-353 : 106 Stat. 941 : August 26, 1992
- Prescription Drug User Fee Act of 1992 : P.L. 102-571 : 106 Stat. 4491 : October 29, 1992
- Prescription Drug User Fee Act of 1992 : report (to accompany H.R. 5952) (including cost estimate of the Congressional Budget Office)
- Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997 : report, together with additional views (to accompany H.R. 1411) (including cost estimate of the Congressional Budget Office)
- Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to Congressional requesters
- Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to congressional requesters
- Protecting Patient Access to Emergency Medications Act of 2016 : report (to accompany H.R. 4365)
- Providing for consideration of H.R. 2427, Pharmaceutical Market Access Act of 2003 : report (to accompany H. Res. 335)
- Providing for the consideration of H.R. 2260, Pain Relief Promotion Act of 1999 : report (to accompany H. Res. 339)
- Psychotoxic drug control act of 1964 ; : report to accompany S. 2628
- Pure food : securing the Federal Food and Drugs Act of 1906
- RX : medication error liability
- Reauthorization of PDUFA : what it means for jobs, innovation, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 1, 2012
- Regulation of pharmaceutical innovation: the 1962 amendments
- Regulation of pharmaceutical manufacturers
- Regulation of trade in drugs. : Hearings, Ninety-first Congress, second session, on S. 1575 ... June 16 and 17, 1970
- Reinventing regulation of drugs and medical devices
- Reorganization plan no. 1 of 1968; drug abuse and narcotics ; : and H. Res. 1101. Hearings, Ninetieth Congress, second session. March 19, 20, and 21, 1968
- Report of the Federal Security Agency: Food and Drug Administration
- Requirements of the United States Food, drug, and cosmetic act
- Review of transitional provisions in Drug amendments of 1962. : Hearings, Ninety-second Congress, first session ...
- Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996
- S. 1082, the Food and Drug Administration Revitalization Act
- S. 334 : an approach to drug importation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining S. 334, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, April 19, 2005
- Safe Doses Act, the Counterfeit Drug Penalty Enhancement Act of 2011, and the Foreign Counterfeit Prevention Act : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, on H.R. 4223, H.R. 3668, and H.R. 4216, March 28, 2012
- Seized by the law
- Special federal food and drug laws : statutes, regulations, legislative history, annotations
- State Rewards Program Update and Technical Corrections Act of 2012 : report (to accompany S. 2318)
- Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 : report together with dissenting views (to accompany H.R. 2851) (including cost estimate of the Congressional Budget Office)
- Summary of H.R. 17463, a bill to regulate controlled dangerous substances and to amend the narcotics and drugs laws
- Summary of recommendations on H.R. 17463 : a bill to regulate controlled dangerous substances and to amend the narcotics and drug laws
- Symposium : emerging issues in food and drug law : a national conference for lawyers, policy-makers, and corporate leaders
- Taking your medicine : drug regulation in the United States
- The Food and Drug Act of 1906 : S.88, 59th Congress, 1st session, P.L. 59-384
- The Food and Drugs Act, June 30, 1906 : a study with text of the act, annotated, the rules and regulations for the enforcement of the act, food inspection, decisions and official food standards
- The Legislative history of the Drug Price Competition and Patent Term Restoration Act of 1984
- The MDMA controversy : contexts of use and social control
- The Pain Relief Promotion Act : report together with minority views (to accompany H.R. 2260)
- The cure in the code : how 20th century law is undermining 21st century medicine
- The drug amendments of 1962 : legislative history, reports, bills, debate, act
- The history of the United States food and drug law : the federal Food and Drugs Act : addresses
- The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
- The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
- The law of drugs and druggists ; : a treatise with text, cases, statutes, readings, and digests for schools of pharmacy, retail, wholesale, and manufacturing druggists
- The pharmaceutical regulatory process
- The revision of the federal Food and Drugs Act : from the standpoint of the drug industry : an address delivered on November 27, 1934 at the monthly luncheon meeting of the Drug, Chemical and Allied Trades Section of the New York Board of Trade, Inc., at the Hotel McAlpin, in New York City
- The safety and effectiveness of new drugs (market withdrawal of drugs containing cyclamates). : Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 3, 1971
- The safety and effectiveness of new drugs (standards for evaluating drug effectiveness--enforcement problems). : Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 5, 1971
- The safety and effectiveness of new drugs : (marketing of fixed combination drugs and unapproved new drugs; implementation of drug efficacy findings). Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 26, 1971
- To amend section 503 (b) of the Federal food, drug and cosmetic act of 1938, as amended. : Hearings, Eighty-second Congress, first session, on S. 1186 and H.R. 3298. September 11, 12, and 13, 1951
- To amend the federal food, drug, and cosmetic act : hearings before a subcomittee of the committee ... Eighty-first Congress, first session on H.R. 3151, a bill to amend the federal food, drug, and cosmetic act of June 25, 1938, as amended by providing for the certification of batches of drugs composed wholly or partly of any kind of aureomycin, chloramphenecol, and bactracin, or any derivative thereof; H.R. 562, a bill to amend section 801 (d) of the federal food, drug, and cosmetic act, as amended, in relation to exports; H.R. 160, a bill to amend section 801 of the federal food, drug, and cosmetic act, as amended. April 12, 28, and May 2, 1949
- To apply counterinsurgency tactics under a coordinated and targeted strategy to combat the terrorist insurgency in Mexico waged by transnational criminal organizations, and for other purposes; and to withhold twenty percent of United States assessed and voluntary contributions to the Organization of American States (OAS) for every Permanent Council meeting that takes place where Article 20 of the Inter-American Charter is not invoked with regard to Venezuela's recent constitutional reforms, and for other purposes : markup before the Subcommittee on the Western Hemisphere of the Committee on Foreign Affairs, House of Representatives, One Hundred Twelfth Congress, first session, on H.R. 3401 and H.R. 2542, December 15, 2011
- VA Prescription Data Accountability Act 2017 : report (to accompany H.R. 1545) (including cost estimate of the Congressional Budget Office)
- What's all the hullabaloo about pharmaceutical litigation?
- Wheeler-Lea act : a statement of its legislative record
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/kSnHyi50WJ8/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/kSnHyi50WJ8/">Drugs -- Law and legislation -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library - University of Pennsylvania Law School</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Drugs -- Law and legislation -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/kSnHyi50WJ8/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/kSnHyi50WJ8/">Drugs -- Law and legislation -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library - University of Pennsylvania Law School</a></span></span></span></span></div>
